A universal flu vaccine aims to target the core structure of the influenza family, rather than just the prevalent strains each season. Current vaccines are often only about 60% effective, as they rely on predictions of which strains will dominate. A leading expert estimates that achieving a universal vaccine could take a decade and cost around $200 million, with a 75% chance of success.
